Dimitrow Pawel Petkow, Hlawaty Marta, Undas Anetta, Sniezek-Maciejewska Maria, Sobień Bartosz, Stepień Ewa, Tracz Wiesława
Institute of Cardiology, Collegium Medicum Jagiellonian University, ul. Kopernika 17, 31-501 Krakow, Poland.
Atherosclerosis. 2009 Jun;204(2):e103-8. doi: 10.1016/j.atherosclerosis.2008.12.029. Epub 2008 Dec 30.
The aim of study was to assess whether activation of blood coagulation and platelets is enhanced in aortic stenosis (AS) and if so, to determine factors that might modulate these processes.
PATIENTS/METHODS: Seventy-five patients with AS (48 males, 27 females, aged 65+/-10 years) were enrolled in the study. A control group comprised 75 age- and sex-matched subjects. We determined markers of thrombin generation (thrombin-antithrombin complex [TAT], prothrombin fragment 1+2 [F1+2]), platelet activation (soluble CD40 ligand [sCD40L], beta-thromboglobulin [beta-TG], P-selectin) in peripheral blood plasma. The extent of atherosclerosis in the carotid and coronary arteries was assessed as a potential confounding factor.
Mean concentrations of thrombin and platelet markers were higher approximately two-fold in the AS group than in controls (p<0.005 for all comparisons). Maximal gradient was positively associated with TAT (r=0.61, p<0.001), F1+2 (r=0.60, p<0.001), sCD40L (r=0.52, p<0.01) and beta-TG (r=0.70, p<0.001). Aortic valve area (AVA) negatively associated only with one platelet marker, beta-TG (r=-0.30, p<0.05). The presence of concomitant atherosclerotic plaque in the carotid (in 65% of patients) or coronary arteries (in 43% of patients) did not influence thrombin generation and platelet activation in patients with AS.
AS predisposes to prothrombotic state. Maximal gradient as an index of turbulent flow associated with activation of coagulation and platelets. In contrast, the small aortic valve area was not closely related to these parameters.
本研究旨在评估主动脉瓣狭窄(AS)患者的凝血和血小板激活是否增强,若增强,则确定可能调节这些过程的因素。
患者/方法:75例AS患者(48例男性,27例女性,年龄65±10岁)纳入本研究。对照组由75例年龄和性别匹配的受试者组成。我们测定了外周血浆中凝血酶生成标志物(凝血酶 - 抗凝血酶复合物 [TAT]、凝血酶原片段1 + 2 [F1 + 2])、血小板激活标志物(可溶性CD40配体 [sCD40L]、β-血小板球蛋白 [β-TG]、P-选择素)。评估颈动脉和冠状动脉的动脉粥样硬化程度作为潜在混杂因素。
AS组凝血酶和血小板标志物的平均浓度比对照组高约两倍(所有比较p < 0.005)。最大梯度与TAT(r = 0.61,p < 0.001)、F1 + 2(r = 0.60,p < 0.001)、sCD40L(r = 0.52,p < 0.01)和β-TG(r = 0.70,p < 0.001)呈正相关。主动脉瓣面积(AVA)仅与一种血小板标志物β-TG呈负相关(r = -0.30,p < 0.05)。颈动脉(65%患者)或冠状动脉(43%患者)存在合并动脉粥样硬化斑块并不影响AS患者的凝血酶生成和血小板激活。
AS易导致血栓前状态。最大梯度作为与凝血和血小板激活相关的湍流指标。相比之下,小主动脉瓣面积与这些参数没有密切关系。